Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Applied Behavior Analysis|September 24, 2011
The effects of a rectangular rapid-flashing beacon on vehicle speedMichelle VanWagner, Ron Van Houten, Brian Betts
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 30, 2021
Hemophagocytic lymphohistiocytosis induced by Toxoplasma gondii infection diagnosed by a bone marrow biopsy and DNA next-generation sequencing in an allogeneic hematopoietic stem cell transplant recipientKaram M Obeid, Bartosz Grzywacz, Patricia Ferrieri, et al.
Haematologica|July 28, 2011
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
JCO Clinical Cancer Informatics|March 20, 2026
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple MyelomaEhsan Malek, Brian Betts, Megan Herr, et al.
Bone Marrow Transplantation|June 14, 2018
Hepatic veno-occlusive disease following sirolimus-based immune suppressionFarhad Khimani, George B McDonald, Howard M Shulman, et al.
Transplantation and Cellular Therapy|January 22, 2023
Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell TransplantationNuttavut Sumransub, Qing Cao, Mark Juckett, et al.
Journal of Thrombosis and Haemostasis : JTH|February 4, 2023
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactionsJoan D Beckman, Angelica DaSilva, Elena Aronovich, et al.
Blood|August 3, 2013
Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host diseaseAnandharaman Veerapathran, Joseph Pidala, Francisca Beato, et al.
Leukemia & Lymphoma|March 6, 2020
Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasiaElizabeth DiMaggio, Jun-Min Zhou, Ryan Caddell, et al.
Oncoimmunology|July 30, 2016
CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in miceJessica Heinrichs, Jun Li, Hung Nguyen, et al.
Pageof 2